Posted Mar. 13, 2017 at 6:20 a.m.

Premium Lock Immunology synergy drives Heat Bio's acquisition play

Published: 2017-03-13 06:20:00
Updated: 2017-03-13 06:20:00

Jeff Wolf Jeff Wolf (Heat Bio photo)

Early this month, Heat Biologics acquired an 80 percent controlling interest in Pelican Therapeutics. The company says combining its technology with Pelican's and possibly other immunotherapies provides a synergistic treatment expected to be more effective than those used alone....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders